Skip to main content
. 2013 Jan 22;8(1):e53960. doi: 10.1371/journal.pone.0053960

Table 3. Tumor recurrence rates in patients meeting and exceeding the Milan/UCSF criteria, according to IBT.

IBT (n = 59) non-IBT (n = 34) P-value
Milan In (n; %) 4/37 (10.8%) 3/20 (15%) 0.65
Milan Out (n; %) 7/22 (31,8%) 7/14 (50%) 0.28
UCSF In (n; %) 4/41 (9.8%) 4/24 (16.7%) 0.41
UCSF Out (n; %) 7/18 (38.9%) 6/10 (60%) 0.28

UCSF: University of California San Francisco.